The company ended the third quarter of 2025 with $715 million in cash, a war chest deemed sufficient to fund both ongoing VANQUISH trials to completion. Research and development expenses jumped to $90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback